Skip to content

Diagnostic Breath Analysis Study to Detect Sepsis

Pilot Study to Evaluate Diagnostic Breath Analysis for Early Detection of Systemic Inflammatory Response Syndrome (SIRS) and Sepsis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02532959
Enrollment
10
Registered
2015-08-26
Start date
2015-06-30
Completion date
2015-09-30
Last updated
2016-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Puerperal: [Major Infection] or [Sepsis]

Brief summary

Analysis of exhaled breath samples using a high-speed gas chromatography medical device will identify Volatile Organic Compounds (VOC) that are specifically associated with SIRS and Sepsis. Primary outcome measures will include the assessment of the zNose Diagnostic Breath Analysis System, which includes high-speed gas chromatography, in the early detection of SIRS and Sepsis as compared with current SIRS and Sepsis evaluation methods.

Detailed description

Exhaled breath samples were collected in a Tedlar bag or with a proprietary collection tube. The collection devices are clean and intended for single-use. They are manufactured with approved medical grade materials. Patients were asked to breath into a single-use, medical grade mouthpiece which is connected to the collection bag or tube. The design of the collection devices does not allow the patient to rebreathe the exhaled gas sample. Patients enrolled in the clinical study were asked to breathe into the breath collection device for 2 to 4 breaths. Breath collection is completely non-invasive. Breath samples were held for 30 days and retested at the end of the 30 day period to determine if the VOC profile has changed over time.

Interventions

DEVICEDiagnostic Breath Analysis

Conduct exhaled breath samples

Sponsors

Landon Pediatric Foundation
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

Inclusion Criteria 1. Age 18 years of age or older 2. Able to give written and dated informed consent prior to any study specific procedures. 3. Able to follow instructions for specific breathing maneuvers. 4. Able to breath into a medical grade tube, vial or bag. 5. Initial assessment and screening indicates SIRS or Sepsis.

Design outcomes

Primary

MeasureTime frameDescription
Diagnostic Breath Analysis6 monthsDiagnostic Breath Analysis to identify Volatile Organic Compounds (VOC) associated with Sepsis and SIRS

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026